This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/7/2024
Please stand by, your program is about to begin. If you need assistance on today's conference, please press star zero. Good day, everyone, and welcome to the Senseonics third quarter 2024 earnings call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question and answer session. You may register to ask a question at any time by pressing star and one on your telephone keypad You may withdraw yourself from the queue by pressing Start To. Please note, this call may be recorded. I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Jeremy Pfeffer, LifeSci Advisors.
Thank you. This is Jeremy Pfeffer from LifeSci Advisors. Before we begin today, let me remind you that the company's remarks include forward-looking statements. These statements reflect management's expectations about future events, operating plans, regulatory matters, product enhancements, company performance, and other matters, and speak only as of the date hereof. These forward-looking statements involve a number of risks and uncertainties. A list of these factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is detailed under risk factors and elsewhere in our annual report on Form 10-K for the year end of December 31st, 2023, our quarterly report on Form 10-Q for the quarter ended September 30th, 2024, and our other reports filed with the SEC. These documents are available in the investor relations section of our website at www.senseonics.com. We undertake no obligation to update publicly or revise these forward-looking statements for any reason except as required by law. Joining me today from Senseonics are Tim Goodenow, President and Chief Executive Officer, and Rick Sullivan, Chief Financial Officer. Today, we also have Brian Hanson, President of CGM at Ascensia Diabetes Care, our global distribution partner for Eversense, joining us. With that, I would like to turn the call over to Tim Goodenow, President and CEO.
Tim?
You're reading a preview of the SENS Q3 2024 earnings call.
Free account.
